Whone AL - Search Results

1

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, Lang AE, Rascol O, Ribeiro MJ, Remy P, Poewe WH, Hauser RA, Brooks DJ; REAL-PET Study Group. Whone AL, et al. Ann Neurol. 2003 Jul;54(1):93-101. doi: 10.1002/ana.10609. Ann Neurol. 2003. PMID: 12838524 Clinical Trial.

2

Plasticity of the nigropallidal pathway in Parkinson's disease.

Whone AL, Moore RY, Piccini PP, Brooks DJ. Whone AL, et al. Ann Neurol. 2003 Feb;53(2):206-13. doi: 10.1002/ana.10427. Ann Neurol. 2003. PMID: 12557287

3

Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study.

Moore RY, Whone AL, McGowan S, Brooks DJ. Moore RY, et al. Among authors: whone al. Brain Res. 2003 Aug 29;982(2):137-45. doi: 10.1016/s0006-8993(03)02721-5. Brain Res. 2003. PMID: 12915249

4

Functional brain imaging in the differential diagnosis of Parkinson's disease.

Piccini P, Whone A. Piccini P, et al. Lancet Neurol. 2004 May;3(5):284-90. doi: 10.1016/S1474-4422(04)00736-7. Lancet Neurol. 2004. PMID: 15099543 Review.

5

A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study.

Whone AL, Bailey DL, Remy P, Pavese N, Brooks DJ. Whone AL, et al. J Nucl Med. 2004 Jul;45(7):1135-45. J Nucl Med. 2004. PMID: 15235059 Free article. Clinical Trial.

6

Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's disease.

Fern-Pollak L, Whone AL, Brooks DJ, Mehta MA. Fern-Pollak L, et al. Among authors: whone al. Neuropsychologia. 2004;42(14):1917-26. doi: 10.1016/j.neuropsychologia.2004.05.004. Neuropsychologia. 2004. PMID: 15381022 Clinical Trial.

7

Opioid binding in DYT1 primary torsion dystonia: an 11C-diprenorphine PET study.

Whone AL, Von Spiczak S, Edwards M, Valente EM, Hammers A, Bhatia KP, Brooks DJ. Whone AL, et al. Mov Disord. 2004 Dec;19(12):1498-503. doi: 10.1002/mds.20238. Mov Disord. 2004. PMID: 15390064

8

The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study.

von Spiczak S, Whone AL, Hammers A, Asselin MC, Turkheimer F, Tings T, Happe S, Paulus W, Trenkwalder C, Brooks DJ. von Spiczak S, et al. Among authors: whone al. Brain. 2005 Apr;128(Pt 4):906-17. doi: 10.1093/brain/awh441. Epub 2005 Feb 23. Brain. 2005. PMID: 15728657

9

Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study.

Moore RY, Whone AL, Brooks DJ. Moore RY, et al. Among authors: whone al. Neurobiol Dis. 2008 Mar;29(3):381-90. doi: 10.1016/j.nbd.2007.09.004. Epub 2007 Sep 26. Neurobiol Dis. 2008. PMID: 18226536

10

Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET study.

Pavese N, Rivero-Bosch M, Lewis SJ, Whone AL, Brooks DJ. Pavese N, et al. Among authors: whone al. Neuroimage. 2011 Jun 1;56(3):1463-8. doi: 10.1016/j.neuroimage.2011.03.012. Epub 2011 Mar 17. Neuroimage. 2011. PMID: 21396455

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters